Why Sangamo Therapeutics Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
Why Sangamo Therapeutics Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
为什么Sangamo Therapeutics的股票在盘前交易中上涨约20%；这里有20只股票在盘前交易中波动。
Here are some other stocks moving in pre-market trading.Shares of Sangamo Therapeutics, Inc. (NASDAQ:SGMO) rose sharply in today's pre-market trading.
Sangamo Therapeutics, Inc.（纳斯达克股票代码：SGMO）的股价在今天的盘前交易中大幅上涨。
Astellas and Sangamo Therapeutics disclosed Capsid license agreement to deliver genomic medicines for neurological diseases.
安斯泰来和Sangamo Therapeutics披露了为神经系统疾病提供基因组药物的Capsid许可协议。
Sangamo Therapeutics shares jumped 19.5% to $2.81 in the pre-market trading session.
Sangamo Therapeutics的股价在盘前交易时段上涨了19.5％，至2.81美元。
Here are some other stocks moving in pre-market trading.
以下是盘前交易中其他一些股票。
Gainers
赢家
- CURRENC Group Inc. (NASDAQ:CURR) gained 219.5% to $6.39 in pre-market trading after jumping 54% on Wednesday.
- XChange TEC.INC (NASDAQ:XHG) climbed 170% to $2.13 in pre-market trading after declining over 50% on Wednesday.
- AppTech Payments Corp. (NASDAQ:APCX) gained 170% to $1.03 in pre-market trading.
- Silexion Therapeutics Corp (NASDAQ:SLXN) gained 68% to $3.55 in pre-market trading after dropping 26% on Wednesday.
- Mesoblast Limited (NASDAQ:MESO) rose 44.5% to $17.70 in pre-market trading. Mesoblast's RYONCIL became the first FDA-approved mesenchymal stromal cell therapy in the U.S.
- Elevai Labs Inc. (NASDAQ:ELAB) gained 38.6% to $2.98 in pre-market trading after gaining 9% on Wednesday.
- Dallasnews Corp (NASDAQ:DALN) gained 38% to $6.72 in pre-market trading after falling 5% on Wednesday.
- KULR Technology Group, Inc. (NASDAQ:KULR) rose 28% to $2.68 in pre-market trading after jumping 44% on Wednesday.
- XCHG Limited (NASDAQ:XCH) gained 24.2% to $2.67 in pre-market trading after dipping more than 90% on Wednesday.
- CURRENC集团公司（纳斯达克股票代码：CURR）在周三上涨54％后，在盘前交易中上涨219.5％，至6.39美元。
- xChange TEC.INC（纳斯达克股票代码：XHG）在周三下跌超过50％后，在盘前交易中上涨了170％，至2.13美元。
- AppTech Payments Corp.（纳斯达克股票代码：APCX）在盘前交易中上涨170％，至1.03美元。
- Silexion Therapeutics Corp（纳斯达克股票代码：SLXN）在周三下跌26％后，在盘前交易中上涨68％，至3.55美元。
- Mesoblast Limited（纳斯达克股票代码：MESO）在盘前交易中上涨44.5％，至17.70美元。Mesoblast的RYONCIL成为美国第一种获得美国食品药品管理局批准的间充质基质细胞疗法。
- Elevai Labs Inc.（纳斯达克股票代码：ELAB）在周三上涨9％后，在盘前交易中上涨38.6％，至2.98美元。
- 达拉斯新闻公司（纳斯达克股票代码：DALN）在周三下跌5％后，在盘前交易中上涨38％，至6.72美元。
- KULR科技集团公司（纳斯达克股票代码：KULR）在周三上涨44％后，在盘前交易中上涨28％，至2.68美元。
- XCHG有限公司（纳斯达克股票代码：XCH）在周三下跌超过90％后，在盘前交易中上涨24.2％，至2.67美元。
Losers
失败者
- Snow Lake Resources Ltd. (NASDAQ:LITM) shares tumbled 40.5% to $0.4847 in pre-market trading after jumping 348% on Wednesday.
- Aethlon Medical, Inc. (NASDAQ:AEMD) declined 36.4% to $0.42 in pre-market trading after jumping more than 80% on Wednesday.
- Abacus Life, Inc. (NASDAQ:ABL) shares fell 20.5% to $6.00 in pre-market trading.
- Lamb Weston Holdings, Inc. (NYSE:LW) shares dipped 18.6% to $63.50 in pre-market trading as the company posted downbeat quarterly results and lowered FY25 outlook.
- Nvni Group Limited (NASDAQ:NVNI) fell 18.5% to $0.5213 in today's pre-market trading after jumping 52% on Wednesday.
- Micron Technology, Inc. (NASDAQ:MU) dipped 15.6% to $87.60 in pre-market trading. Micron posted better-than-expected earnings for its first quarter, while sales missed expectations. The company said it sees second-quarter revenue of $7.9 billion, plus or minus $200 million, versus estimates of $9 billion. The company expects second-quarter adjusted earnings of $1.43 per share, plus or minus 10 cents per share, versus estimates of $1.92 per share.
- Virax Biolabs Group Limited (NASDAQ:VRAX) fell 15.6% to $2.00 in pre-market trading after surging 39% on Wednesday.
- Quantum BioPharma Ltd. (NASDAQ:QNTM) shares fell 14.5% to $2.95 in pre-market trading after dipping 18% on Wednesday.
- Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) fell 14.3% to $0.3008 in pre-market trading following a 30% plunge on Wednesday.
- Design Therapeutics, Inc. (NASDAQ:DSGN) fell 14.2% to $5.10 in pre-market trading after declining 5% on Wednesday.
- 雪湖资源有限公司（纳斯达克股票代码：LITM）股价在周三上涨348％后，在盘前交易中下跌40.5％，至0.4847美元。
- Aethlon Medical, Inc.（纳斯达克股票代码：AEMD）在周三上涨超过80％后，在盘前交易中下跌36.4％，至0.42美元。
- 盘前交易中，Abacus Life, Inc.（纳斯达克股票代码：ABL）股价下跌20.5％，至6.00美元。
- 兰姆·韦斯顿控股公司（纽约证券交易所代码：LW）股价在盘前交易中下跌18.6％，至63.50美元，原因是该公司公布了悲观的季度业绩并下调了25财年展望。
- Nvni集团有限公司（纳斯达克股票代码：NVNI）在周三上涨52％后，在今天的盘前交易中下跌18.5％，至0.5213美元。
- 美光科技公司（纳斯达克股票代码：MU）在盘前交易中下跌15.6％，至87.60美元。美光公布的第一季度收益好于预期，而销售额未达到预期。该公司表示，预计第二季度收入为79亿美元，正负2亿美元，而预期为90亿美元。该公司预计，第二季度调整后每股收益为1.43美元，正负每股收益10美分，而预期为每股1.92美元。
- Virax Biolabs集团有限公司（纳斯达克股票代码：VRAX）在周三飙升39％后，在盘前交易中下跌15.6％，至2.00美元。
- 量子生物制药有限公司（纳斯达克股票代码：QNTM）股价在周三下跌18％后，在盘前交易中下跌了14.5％，至2.95美元。
- 彼得罗斯制药公司（纳斯达克股票代码：PTPI）在周三暴跌30％之后，在盘前交易中下跌14.3％，至0.3008美元。
- Design Therapeutics, Inc.（纳斯达克股票代码：DSGN）在周三下跌5％后，在盘前交易中下跌14.2％，至5.10美元。
Now Read This:
现在阅读这篇文章：
- Top 3 Tech And Telecom Stocks That May Crash This Month
- 本月可能暴跌的三大科技和电信股票